ACTIVITY DESCRIPTION
Join expert Stefan Gravenstein, MD, MPH for this CME/CNE-certified activity and get an in-depth look at the latest protocols and processes for vaccine selection and administration including:
- Protocols to ensure more patients get their annual flu vaccines
- Different types of flu vaccines: how to choose one
LEARNING OBJECTIVES
Upon completion of this educational activity, learners should be better able to:
- Advise patients and families regarding the high-benefit/low-risk profile of universal influenza vaccination
- Implement protocols and processes for offering and administering vaccines to all patients in a practice or hospital setting
FACULTY
Stefan Gravenstein, MD, MPH,
Professor of Medicine
Director, Center for Geriatrics and Palliative Care
University Hospitals and Case Western Reserve University
Cleveland, OH Adjunct Professor of Medicine
Brown University Providence, RI
FACULTY BIOGRAPHY
Stefan Gravenstein, MD, MPH, is Professor of Medicine at Case Western Reserve University School of Medicine in Cleveland, Ohio. He serves as interim Chief of the Division of Geriatrics and Palliative Care at Case Western Reserve University and as Director of the Center for Geriatrics and Palliative Care at University Hospitals-Case Medical Center. He is also Adjunct Professor of Medicine at The Warren Alpert Medical School and School of Public Health at Brown University in Providence, Rhode Island. Dr Gravenstein received his medical degree from The Ohio State University in Columbus. He completed his residency at University of Wisconsin Hospitals and Clinics, followed by a geriatrics fellowship and postdoctoral training at William S. Middleton Veterans Hospital, both in Madison, Wisconsin. He received his master of public health from Eastern Virginia Medical School/Old Dominion University in Norfolk.
Dr Gravenstein has a longstanding interest in immunity, inflammation, and aging, especially in the context of influenza, vaccination, and nursing-home care. He also has a specific interest in quality improvement in healthcare, the culture of care, and how to improve care across care transitions. He has served as Principal Investigator or Co-Investigator on multiple research grants and clinical trials, investigating these topics with uninterrupted competitive funding since 1989. He has authored more than 120 peer-reviewed articles and 20 books and book chapters. In addition, Dr Gravenstein currently serves as clinical section editor for Gerontology, and he is a reviewer for several journals. He is a member of many professional societies including the American College of Physicians, American Geriatrics Society, Gerontological Society of America, American Medical Directors Association, and American Medical Association.
DISCLOSURE STATEMENTS
According to the disclosure policy of the Academy, all faculty, planning committee members, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant relationships with any commercial interests related to this activity. The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation. All educational materials are reviewed for fair balance, scientific objectivity, and levels of evidence. Disclosures are as follows:
Stefan Gravenstein, MD, MPH
Advisory Board, consultant – for marketing purposes: Sanofi-Aventis
Advisory Board – for scientific information: Janssen Pharmaceuticals, Inc.; Pfizer, Inc.
Consultant – for clinical trial design: Merck
Grant Recipient/Research Support: Sanofi-Aventis
Promotional Speaker’s Bureau: Sanofi-Aventis
Other grant support: Agency for Healthcare Research and Quality; The Cleveland Foundation;
The McGregor Foundation; and National Institute of Allergy and Infectious Diseases
Independent Clinical Peer Reviewer
Christianne N. Fowler, BSN, MS, DNP
Assistant Professor, Old Dominion University, School of Nursing
Assistant Professor, Eastern Virginia Medical School Norfolk, VA
No relevant financial relationships with any commercial interests.
Planning Committee
American Academy of CME
John JD Juchniewicz, MCIS, CHCP
No relevant financial relationships with any commercial interests.
Natalie Kirkwood, RN, BSN, JD, Lead Nurse Planner
No relevant financial relationships with any commercial interests.
Spire Learning
Lisa Conklin
No relevant financial relationships with any commercial interests.
Jeanne Prater
Shareholder (spouse/partner): Johnson & Johnson
Employee (spouse/partner): Novo Nordisk
Jaime Symowicz, PhD
No relevant financial relationships with any commercial interests.
Lauren Waters
No relevant financial relationships with any commercial interests.
DISCLAIMER
The opinions expressed in this educational activity are those of the faculty, and do not represent those of Academy, Spire Learning, or American Nurses Credentialing Center’s Commission on Accreditation. This activity is intended as a supplement to existing knowledge, published information, and practice guidelines. Learners should appraise the information presented critically, and draw conclusions only after careful consideration of all available scientific information.
Recommendations made in this educational activity were based on guidance from the CDC for the 2014-2015 influenza season. Participants are encouraged to also consult the guidance for the 2015-2016 influenza season below:
Updates for the 2015-2016 Influenza Season
Click here for recommendations from the CDC’s Advisory Committee on Immunization Practices. http://www.cdc.gov/flu/professionals/acip/index.htm
Updated information for 2015-2016 includes:
- Antigenic composition of U.S. seasonal influenza vaccines
- Information on influenza vaccine products expected to be available for the 2015–2016 season
- An updated algorithm for determining the appropriate number of doses for children aged 6 months through 8 years
- Recommendations for the use of live attenuated influenza vaccine (LAIV) and inactivated influenza vaccine (IIV) when either is available, including removal of the 2014–2015 preferential recommendation for LAIV for healthy children aged 2 through 8 years.
OFF-LABEL STATEMENT
This educational activity contains discussion of published and/or investigational uses of agents that are not indicated by the FDA, specifically the use of neuraminidase inhibitors beyond 48 hours of influenza symptom onset. Faculty have been asked to indicate such discussion at the time of their mention. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. The opinions expressed in this educational activity are those of the faculty, and do not represent those of the Academy or Spire Learning. This activity is intended as a supplement to existing knowledge, published information, and practice guidelines. Learners should appraise the information presented critically, and draw conclusions only after careful consideration of all available scientific information.
LEVELS OF EVIDENCE
Levels of evidence are provided for any patient care recommendations made during this program.
Level A (randomized controlled trial/meta-analysis):
High-quality, randomized controlled trial (RCT) that considers all important outcomes. High-quality meta-analysis (quantitative systematic review) using comprehensive search strategies
Level B (other evidence):
A well-designed, nonrandomized clinical trial. A nonquantitative systematic review with appropriate search strategies and well-substantiated conclusions. Includes lower-quality RCTs, clinical cohort studies, and case-controlled studies with nonbiased selection of study participants and consistent findings. Other evidence, such as high-quality, historical, uncontrolled studies, or well-designed epidemiologic studies with compelling findings, is also included
Level C (consensus/expert opinion):
Consensus viewpoint or expert opinion
DISCLAIMER: Please note that the polling questions in this enduring activity are informational only and are not interactive.
TARGET AUDIENCE
- Emergency medicine physicians
- Hospitalists
- Primary care providers
- Pediatricians
- Geriatricians
- Obstetricians
- NPs
- PAs
- Nurses
ACCREDITATION
Physicians
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of American Academy of CME, Inc., (Academy) and Spire Learning. American Academy of CME, Inc., is accredited by the ACCME to provide continuing medical education for physicians.
American Academy of CME, Inc., designates this enduring material for a maximum of 0.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses
American Academy of CME, Inc., is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
American Academy of CME, Inc., designates this educational activity for 0.50 contact hours (0.5 pharmacotherapeutic contact hours).
ANCC Accreditation Feedback Line: 1-866-262-9730
The Accreditation Program of the American Nurses Credentialing Center is interested in the opinions and perspectives of the participants in accredited continuing nursing education activities, particularly those perspectives related to the presence of perceived bias* in the continuing education. For this reason, we are now providing a toll-free telephone number. Participants may access this number at any time to:
- Tell us of any noted bias or conflict of interest in the education
- Tell us of any concerns, compliments, or opinions
- Tell us of a great experience
- Tell us of an unpleasant experience
- Tell us your thoughts on the process
Just call and tell us!
1-866-262-9730
METHOD OF PARTICIPATION
This activity has no fee and should take approximately 30 minutes to complete. Participants should first read the objectives and other introductory CE information, then complete the pre-assessment and participate in the online case activity. To receive credit for this activity, participants must complete the post-assessment with a passing score of 70% and then complete the evaluation. Your certificate can be printed immediately. This activity is valid through October 29, 2016. No credit will be awarded after this date.
This educational activity is jointly provided by American Academy of CME, Inc., and Spire Learning.
This activity is supported by an educational grant from Genentech.
CONTACT
For any CE questions, please contact: CEServices@academycme.org.
For technical question, please contact info@rapidcme.com.
PRIVACY
For more information about the American Academy of CME privacy policy, please access http://www.academycme.org/privacy.htm.
HARDWARE/SOFTWARE REQUIREMENTS
Hardware-software Requirements
Copyright
©2015. This CME/CNE-certified activity is held as copyrighted by American Academy of CME and Spire Learning. Through this notice, the Academy and Spire Learning grant permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).